Letters in Applied NanoBioScience was established in 2012 and published its first issue on 30 March 2012 as an international, peer-reviewed, open-access journal dedicated to the rapid communication of concise and impactful scientific findings in applied nanobioscience.
From its inception, the journal was conceived as a Letters-format publication, aiming to provide a platform for the timely dissemination of novel experimental results, computational insights, and application-oriented studies at the intersection of nanotechnology, biosciences, applied chemistry, and bio-related materials.
The journal was founded in response to the growing need for short, focused scientific contributions that report emerging concepts, proof-of-principle studies, and early-stage innovations with clear biological, biomedical, environmental, or technological relevance. Emphasis is placed on scientific soundness, reproducibility, and interdisciplinary integration rather than article length.
Since its launch, Letters in Applied NanoBioScience has evolved to reflect advances in nano-enabled biological systems, functional materials, bioactive compounds, and computational approaches supporting applied bioscience. The journal accommodates experimental, theoretical, and in silico studies, provided they offer clear scientific novelty and applied relevance within the Letters format.
The journal’s editorial policies, scope, and publication practices are periodically reviewed to ensure alignment with emerging research trends in nanobioscience and to maintain high standards of editorial integrity, ethical publishing, and scientific quality.